Annual EBITDA
-$167.16 M
+$48.40 M+22.45%
December 31, 2023
Summary
- As of February 12, 2025, BLUE annual EBITDA is -$167.16 million, with the most recent change of +$48.40 million (+22.45%) on December 31, 2023.
- During the last 3 years, BLUE annual EBITDA has risen by +$372.74 million (+69.04%).
- BLUE annual EBITDA is now -1020.61% below its all-time high of -$14.92 million, reached on December 31, 2011.
Performance
BLUE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$39.74 M
+$19.65 M+33.08%
September 30, 2024
Summary
- As of February 12, 2025, BLUE quarterly EBITDA is -$39.74 million, with the most recent change of +$19.65 million (+33.08%) on September 30, 2024.
- Over the past year, BLUE quarterly EBITDA has increased by +$9.73 million (+19.68%).
- BLUE quarterly EBITDA is now -145.02% below its all-time high of $88.28 million, reached on December 31, 2022.
Performance
BLUE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$216.60 M
+$35.77 M+14.17%
September 30, 2024
Summary
- As of February 12, 2025, BLUE TTM EBITDA is -$216.60 million, with the most recent change of +$35.77 million (+14.17%) on September 30, 2024.
- Over the past year, BLUE TTM EBITDA has increased by +$29.41 million (+11.96%).
- BLUE TTM EBITDA is now -4163.72% below its all-time high of -$5.08 million, reached on March 31, 2012.
Performance
BLUE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BLUE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.4% | +19.7% | +12.0% |
| 3 y3 years | +69.0% | -145.0% | -0.5% |
| 5 y5 years | +69.7% | +80.6% | +64.2% |
BLUE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.3% | -145.0% | +70.0% | -1887.7% | +60.6% |
| 5 y | 5-year | at high | +69.4% | -145.0% | +80.3% | -1887.7% | +64.2% |
| alltime | all time | -1020.6% | +69.7% | -145.0% | +80.6% | -4163.7% | +70.0% |
Bluebird Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$39.74 M(-33.1%) | -$216.60 M(-14.2%) |
| Jun 2024 | - | -$59.39 M(+20.0%) | -$252.36 M(+2.6%) |
| Mar 2024 | - | -$49.48 M(-27.2%) | -$246.01 M(+47.2%) |
| Dec 2023 | -$167.16 M(-22.5%) | -$67.98 M(-10.0%) | -$167.16 M(+1434.0%) |
| Sep 2023 | - | -$75.51 M(+42.4%) | -$10.90 M(-46.8%) |
| Jun 2023 | - | -$53.04 M(-280.6%) | -$20.48 M(-69.4%) |
| Mar 2023 | - | $29.37 M(-66.7%) | -$66.86 M(-69.0%) |
| Dec 2022 | -$215.56 M(-60.5%) | $88.28 M(-203.7%) | -$215.56 M(-50.6%) |
| Sep 2022 | - | -$85.09 M(-14.4%) | -$436.19 M(-9.0%) |
| Jun 2022 | - | -$99.42 M(-16.7%) | -$479.39 M(-9.3%) |
| Mar 2022 | - | -$119.33 M(-9.8%) | -$528.68 M(-3.9%) |
| Dec 2021 | -$545.46 M(+1.0%) | -$132.35 M(+3.2%) | -$550.09 M(+0.5%) |
| Sep 2021 | - | -$128.29 M(-13.7%) | -$547.36 M(-9.5%) |
| Jun 2021 | - | -$148.71 M(+5.7%) | -$604.64 M(+26.2%) |
| Mar 2021 | - | -$140.73 M(+8.6%) | -$478.98 M(-11.3%) |
| Dec 2020 | -$539.90 M(-1.0%) | -$129.63 M(-30.1%) | -$539.90 M(+40.2%) |
| Sep 2020 | - | -$185.57 M(+705.1%) | -$385.20 M(-4.8%) |
| Jun 2020 | - | -$23.05 M(-88.6%) | -$404.70 M(-30.2%) |
| Mar 2020 | - | -$201.65 M(-904.3%) | -$580.09 M(+6.3%) |
| Dec 2019 | -$545.53 M(-1.1%) | $25.07 M(-112.2%) | -$545.53 M(-24.3%) |
| Sep 2019 | - | -$205.07 M(+3.3%) | -$720.86 M(+9.0%) |
| Jun 2019 | - | -$198.44 M(+18.8%) | -$661.15 M(+8.9%) |
| Mar 2019 | - | -$167.09 M(+11.2%) | -$606.89 M(+10.0%) |
| Dec 2018 | -$551.87 M | -$150.26 M(+3.4%) | -$551.87 M(+7.1%) |
| Sep 2018 | - | -$145.36 M(+0.8%) | -$515.47 M(+16.0%) |
| Jun 2018 | - | -$144.17 M(+28.6%) | -$444.41 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$112.08 M(-1.6%) | -$365.59 M(+14.6%) |
| Dec 2017 | -$319.15 M(+25.6%) | -$113.86 M(+53.3%) | -$319.15 M(+16.3%) |
| Sep 2017 | - | -$74.30 M(+13.7%) | -$274.53 M(-0.1%) |
| Jun 2017 | - | -$65.36 M(-0.4%) | -$274.89 M(+3.5%) |
| Mar 2017 | - | -$65.64 M(-5.2%) | -$265.64 M(+4.5%) |
| Dec 2016 | -$254.09 M(+60.1%) | -$69.24 M(-7.3%) | -$254.09 M(+9.8%) |
| Sep 2016 | - | -$74.66 M(+33.1%) | -$231.44 M(+17.1%) |
| Jun 2016 | - | -$56.11 M(+3.7%) | -$197.69 M(+4.1%) |
| Mar 2016 | - | -$54.08 M(+16.1%) | -$189.83 M(+19.6%) |
| Dec 2015 | -$158.75 M(+182.7%) | -$46.59 M(+13.9%) | -$158.75 M(+22.2%) |
| Sep 2015 | - | -$40.90 M(-15.2%) | -$129.93 M(+24.4%) |
| Jun 2015 | - | -$48.25 M(+109.8%) | -$104.42 M(+51.4%) |
| Mar 2015 | - | -$23.00 M(+29.4%) | -$68.96 M(+22.8%) |
| Dec 2014 | -$56.15 M(+133.9%) | -$17.78 M(+15.5%) | -$56.15 M(+21.7%) |
| Sep 2014 | - | -$15.39 M(+20.3%) | -$46.16 M(+26.1%) |
| Jun 2014 | - | -$12.79 M(+25.5%) | -$36.62 M(+31.5%) |
| Mar 2014 | - | -$10.19 M(+30.9%) | -$27.86 M(+16.0%) |
| Dec 2013 | -$24.01 M(+2.5%) | -$7.78 M(+33.0%) | -$24.01 M(-4.3%) |
| Sep 2013 | - | -$5.85 M(+45.2%) | -$25.08 M(+3.7%) |
| Jun 2013 | - | -$4.03 M(-36.5%) | -$24.18 M(-2.0%) |
| Mar 2013 | - | -$6.34 M(-28.4%) | -$24.68 M(+5.4%) |
| Dec 2012 | -$23.41 M(+57.0%) | -$8.86 M(+78.9%) | -$23.41 M(+60.9%) |
| Sep 2012 | - | -$4.95 M(+9.5%) | -$14.55 M(+51.6%) |
| Jun 2012 | - | -$4.52 M(-11.0%) | -$9.60 M(+89.0%) |
| Mar 2012 | - | -$5.08 M | -$5.08 M |
| Dec 2011 | -$14.92 M | - | - |
FAQ
- What is bluebird bio annual EBITDA?
- What is the all time high annual EBITDA for bluebird bio?
- What is bluebird bio annual EBITDA year-on-year change?
- What is bluebird bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for bluebird bio?
- What is bluebird bio quarterly EBITDA year-on-year change?
- What is bluebird bio TTM EBITDA?
- What is the all time high TTM EBITDA for bluebird bio?
- What is bluebird bio TTM EBITDA year-on-year change?
What is bluebird bio annual EBITDA?
The current annual EBITDA of BLUE is -$167.16 M
What is the all time high annual EBITDA for bluebird bio?
bluebird bio all-time high annual EBITDA is -$14.92 M
What is bluebird bio annual EBITDA year-on-year change?
Over the past year, BLUE annual EBITDA has changed by +$48.40 M (+22.45%)
What is bluebird bio quarterly EBITDA?
The current quarterly EBITDA of BLUE is -$39.74 M
What is the all time high quarterly EBITDA for bluebird bio?
bluebird bio all-time high quarterly EBITDA is $88.28 M
What is bluebird bio quarterly EBITDA year-on-year change?
Over the past year, BLUE quarterly EBITDA has changed by +$9.73 M (+19.68%)
What is bluebird bio TTM EBITDA?
The current TTM EBITDA of BLUE is -$216.60 M
What is the all time high TTM EBITDA for bluebird bio?
bluebird bio all-time high TTM EBITDA is -$5.08 M
What is bluebird bio TTM EBITDA year-on-year change?
Over the past year, BLUE TTM EBITDA has changed by +$29.41 M (+11.96%)